Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects.
about
Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug DeliveryADVANCE: a multisite trial of bioabsorbable steroid-eluting sinus implants.Safety of inhaled corticosteroids in children.Asthma therapy during pregnancy.Prescribing for osteoporosis following the use of inhaled and oral glucocorticoids in general practice.Ciclesonide: a novel inhaled corticosteroid.Treating allergic rhinitis in pregnancy.Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma.Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.Controversies in the treatment of chronic rhinosinusitis.Mometasone furoate nasal spray for the treatment of asthma.Evaluating the suitability of using rat models for preclinical efficacy and side effects with inhaled corticosteroids nanosuspension formulations.Evaluation of Proper Usage of Glucocorticosteroid Inhalers and Their Adverse Effects in Asthmatic PatientsEfficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up.Rhinitis in the Elderly.Can intranasal corticosteroids cause migraine-like headache?
P2860
Q28396497-2C254C4B-FA01-47F7-9FCD-237954129776Q34226664-0EEEAD7D-C649-403F-A222-AA5A64CBADC9Q34523194-62C49A2A-626E-42EF-B870-DCD4C9E2692FQ35164683-DCE30F5C-584A-4574-8483-D9EFEAF78726Q35826545-39719762-11BC-4B55-8036-DEABCABAFA4AQ35906990-83264E68-6FC6-43CD-95E4-C800693F9E54Q36437216-E0E4ABA6-A9DC-4E55-943D-B44EFD5C59BAQ36455870-32D8F37E-582C-4861-AF54-4DDD33F27A57Q36892408-CDB08664-DD70-4B70-A1A9-BA4E8019FB88Q37775622-553E3713-B1E3-4446-A8D3-A1BD5E9BC58AQ38842838-9F157C68-46CB-451F-ADD0-03DA2646DD3BQ41543788-6898A8C4-6C85-48F2-82D3-4E807D794351Q42428123-55A1CD41-A3FC-4E2E-A232-25012E5BFECFQ42854436-A90ABFAE-47DC-4BA2-921F-982CBA22D943Q50946007-29432D8B-5E04-49FD-A42D-3D2BDFCC5511Q53200781-26A17F41-8522-4FC3-8B94-2AEFE2AE5E00
P2860
Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Inhaled and nasal corticostero ...... s of systemic adverse effects.
@ast
Inhaled and nasal corticostero ...... s of systemic adverse effects.
@en
type
label
Inhaled and nasal corticostero ...... s of systemic adverse effects.
@ast
Inhaled and nasal corticostero ...... s of systemic adverse effects.
@en
prefLabel
Inhaled and nasal corticostero ...... s of systemic adverse effects.
@ast
Inhaled and nasal corticostero ...... s of systemic adverse effects.
@en
P2093
P1476
Inhaled and nasal corticostero ...... s of systemic adverse effects.
@en
P2093
P304
P356
10.1016/S0163-7258(99)00019-4
P577
1999-09-01T00:00:00Z